US:
UK:
JAPAN:
- Report code : CMI-1480
- Industry : Medical Devices
- Published On : May 2019
- Pages : 163 Pages
- Format :
Press Release: Non-Invasive Blood Glucose Monitoring Devices Market to Surpass US$ 74.5 Million by 2026
Press Release: Non-Invasive Blood Glucose Monitoring Devices Market to Surpass US$ 74.5 Million by 2026
Non-Invasive Blood Glucose Monitoring Devices Market– Insights
Non-invasive glucose monitoring holds great promise for improving diabetes management by providing better and pain-free blood glucose measurement leading to expansion of non-invasive blood glucose monitor market in the forecast period. This devices measure blood glucose levels in patients suffering from diabetes, without puncturing the skin, or causing pain or trauma. The frequent change in blood glucose levels in diabetic patients has to be tracked by the glucose monitoring device. Glucose monitoring devices can be invasive or non-invasive, but the non-invasive blood glucose monitoring devices market is increasing due to the need of an economic, compact, painless and convenient device for the patients to use.
The global non-invasive blood glucose monitoring devices market size was valued at US$ 5.1 million in 2017, and is expected to witness a CAGR of 35.0%% over the forecast period (2018 – 2026).
Global Non-Invasive Blood Glucose Monitoring Devices Market Share (%) Analysis, By Technology, 2026
Source: Coherent Market Insights Analysis (2019)
Convenience offered by non-invasive blood glucose monitoring devices over self-monitoring devices is expected to drive non-invasive blood glucose monitoring devices market growth
Non-invasive blood glucose monitoring system requires a less number of finger sticks and enables easy transfer and sharing of data from the device for further analysis. For instance, DiaMonTech GmbH, a Germany-based medical device company has developed a non-invasive glucose monitoring device: DMT Pocket; which non-invasively measures the blood glucose without drawing blood, finger pricking, or a test strip. It measures the blood glucose level simply by relaxing patient’s fingertip on the sensor, and displays the blood glucose levels in 5 to 15 seconds. This device can also communicate with mobile phone, enabling easy access to the information at any time.
Non-invasive Blood Glucose Monitoring Devices Market– Restraints
Non-invasive blood glucose monitoring devices are the next step in continuous glucose monitoring (CGM) devices due to various reasons related to the wearer’s comfort. These non-invasive glucose monitoring devices are based on technology, which detects characterization of the biological properties of the skin or biological fluids such as saliva or tears that can be used to track glucose changes in strictly controlled conditions.
However, none of them provide point accuracy close to that of minimally invasive CGM devices under uncontrolled conditions. This is mainly due to the reason that minimally invasive CGM devices measure glucose concentration subcutaneously with an enzymatic sensor that is in contact with biological fluids containing glucose molecules, whereas non-invasive CGM devices measure skin characteristics modulated by glucose changes that are also sensitive to intrinsic (physiology related) and extrinsic (environment related) factors.
Non-invasive Blood Glucose Monitoring Devices Market - Regional Insights
On the basis of region, the global non-invasive blood glucose monitoring devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most lucrative region in the non-invasive blood glucose monitoring devices market over the forecast period due to factors such as increasing engagement of government healthcare regulatory bodies in promoting intermittent or continuous glucose monitoring among diabetic people. Increasing incidence of diabetes and risk factors associated with it such as binge eating, sedentary lifestyle, and insulin resistance, among others in this region, and higher number of non-invasive glucose monitoring devices currently in the development phase, which are expected to launch in the near future.
In Asia Pacific, the non-invasive blood glucose monitoring devices market size is expected to foresee a rapid growth, owing to expanding healthcare infrastructure in emerging economies such as India, and rising incidence of diabetes in the region. For instance, according to the Asian Diabetes Prevention Initiative, 2013, around 113.9 million adults have diabetes in China and 65.1 million adults were diagnosed with diabetes in India. Moreover, China and India are estimated to account for over half a billion diabetic patients by 2030.
Global Non-Invasive Blood Glucose Monitoring Devices Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026
Source: Coherent Market Insights Analysis (2019)
Non-Invasive Blood Glucose Monitoring Devices Market - Competitive Landscape
Key players operating in the global non-invasive blood glucose monitoring devices market include DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
The development of non-invasive glucose monitoring devices marked a remarkable change in diabetes care, as these devices provide real-time information on blood glucose levels, less invasively than conventional glucose monitoring devices. Non-invasive glucose monitoring automatically and constantly tracks blood glucose levels throughout the day, thus providing information that can be analysed to make informed decisions about managing dietary habits, physical activity, and medication.
Moreover, with non-invasive glucose monitoring devices, one can perform an unlimited amount of measurements and evaluate blood glucose level as it changes throughout the day, as well as overnight.
Market Dynamics
Non-invasive glucose monitoring holds great promise for improving diabetes management by providing better and pain-free blood glucose measurement. Moreover, increasing prevalence of diabetes is expected to drive growth of the market. For instance, according to World Health Organisation (WHO), in 2014, diabetes mellitus, a worldwide epidemic disease affected 422 million people and became the seventh leading cause of death in the U.S.
Healthcare regulatory bodies are focused on increasing awareness regarding continuous glucose monitoring, which will help in the adoption of non-invasive glucose monitoring devices in near future. For instance, National Diabetes Strategy (2016-20) has been developed in Australia to guide national action and priorities to prevent diabetes and support the people suffering from diabetes. However, less accuracy of non-invasive blood glucose monitoring devices can negatively impact the adoption rate of the product in future.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 22 market data tables and 17 figures on "Non-Invasive Blood Glucose Monitoring Devices Market” - Global forecast to 2026”
Asia Pacific Intelligence Center (India): 